4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
45.53%
↑ 18% above average
Average (7y)
38.51%
Historical baseline
Range
High:138.84%
Low:0.00%
Volatility
360.6%
High variability
| Period | Value |
|---|---|
| 2024 | 45.53% |
| 2023 | 20.99% |
| 2022 | 30.79% |
| 2021 | 15.69% |
| 2020 | 20.94% |
| 2019 | 138.84% |
| 2018 | 35.28% |
| 2017 | 0.00% |